Consolidated Statement of Cash Flows (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Operating activities:
Net loss	$ (2,184,487)	$ (988,126)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	100,693	142,935
Amortization of convertible loan discoount	55,174	54,548
Fair value of common stock issued for services	90,000	113,930
Fair value of warrants issued to former officer	0	96,974
Fair value of warrants issued for shares of common stock	0	201,920
Fair value of options issued for services	0	113,233
Fair value of options issued to Directors, Employees and Consultants	1,093,505	234,865
Gain on change in fair value and extinguishment of derivatives liabilities, net	0	(21,420)
Allowance for inventory obsolescence	36,393	88,875
Excess of fair value of common stock and warrants issued in exchange of face amount of demand notes	1,353,110	(34,608)
Effect of changes in:
Inventory	(45,302)	(55,553)
Prepaid expenses and other current assets	3,125	(3,125)
Accounts payable and accrued expenses	(3,402)	(65,644)
Accrued payroll and payroll taxes	13,808	23,417
Advances from distributor	1,375,000	1,090,663
Reduction in advances due to revenues from distributor	(1,855,707)	0
Advances from customers	0	(136,533)
Deferred revenue	0	(147,444)
Net cash provided by operating activities	31,910	708,907
Investing activities:
Purchase of property and equipment	(43,254)	(90,058)
Payments for patents	(25,624)	(30,487)
Net cash used in investing activities	(68,878)	(120,545)
Financing activities:
Proceeds from (payments on) bank loan borrowings	0	(349,276)
Proceeds from convertible notes payable	0	153,000
Payments on convertible notes payable	0	(86,550)
Proceeds from sale of common stock	1,021,500	0
Payment of related party short-term loans	0	(100,000)
Payments of short-term loans	0	(75,349)
Purchase of common stock	0	(25,460)
Net cash provided by (used in) financing activities	1,021,500	(483,635)
Net increase in cash	984,532	104,727
Cash, beginning of period	241,976	137,249
Cash, end of period	1,226,508	241,976
Supplemental disclosures of cash flow information:
Cash paid for interest	5,000	47,359
Cash paid for income taxes	0	0
Supplemental disclosure of non-cash investing and financing activities:
Fair value of warrants issued in connection with convertible note	0	90,106
Conversion of accounts payable and accrued expenses to short-term loan	0	20,349
Fair value of derivative liability recorded upon issuance of convertible note	0	15,149
Conversion of convertible notes payable and accrued interest to common stock	270,878	25,460
Common stock issued upon conversion of notes payable	$ 100,000	$ 0